Company / AR per Share
Serina Therapeutics, Inc. AR per Share History
FY2018-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest AR per Share
$0.05
FY2023
5-year range
$0.00 / $0.05
FY2019-FY2023
Trend
+50007.7%
vs FY2022
Sector context
Sector data unavailable
Latest sector comparison
What the data says
AR per Share changed +50008% YoY in FY2023, a notable deviation from the 4-year average annual change of +12489%.
Based on SEC 10-K filings.
0.05 in FY2023 with a 5-year CAGR of +68.6%.
Improved from $0.00 to $0.05 over the past 2 years.
AR per Share over time
Growth rates
- 3-Year CAGR
- +82.7%
- 5-Year CAGR
- +68.6%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2023, ar per share increased 50007.7% year-over-year.
- Lowest ar per share in the period was in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -18.20 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | AR per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | $0.05 | +50007.7% |
| FY2022 | $0.00 | -84.1% |
| FY2021 | $0.00 | -92.3% |
| FY2020 | $0.01 | +123.1% |
| FY2018 | $0.00 | - |
As of FY2023 · SEC 10-K · Updated Jun 24, 2026